Insights

Innomar Strategies

Unlocking Access Building a National Strategy to Support Canadians with Rare Diseases

Sandra Anderson

Commercialization and Strategy

February 2022

Manufacturers

Commercializing cell and gene therapies in Canada

Innomar Strategies

February 2022

Cell and gene therapies are currently at the forefront of scientific innovation. They hold great promise for patients suffering from a range of serious ailments.

Manufacturers

The Drug Reimbursement Environment in Canada: An Overview

Alison Drinkwater

January 2022

The Canadian environment is a key opportunity for pharmaceutical manufacturers to launch therapies. This article considers the various stakeholders and elements that need to be considered when launching a specialty medication in Canada.

Manufacturers